Thrombin Inhibitor or Factor Xa Inhibitor?
Open Access
- 1 January 2011
- journal article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 75 (8) , 1819-1820
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 10 references indexed in Scilit:
- 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)Circulation, 2011
- Apixaban in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Safety and Efficacy of the Oral Direct Factor Xa Inhibitor Apixaban in Japanese Patients With Non-Valvular Atrial FibrillationCirculation Journal, 2011
- Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -Circulation Journal, 2011
- New AnticoagulantsCirculation, 2010
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationaleAmerican Heart Journal, 2010
- Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008)Circulation Journal, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial FibrillationJACC, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive SummaryCirculation, 2006